EncompaaS Unveils Cutting-Edge AI Contract Validation and Analytics Tool to Boost Pharma Companies’ Competitive Edge

EncompaaS has launched an innovative Contract Validation and Analytics (CVA) tool for pharmaceutical manufacturers, automating the extraction and analysis of drug formulary data. By seamlessly comparing formulary information against contractual obligations, this AI-powered solution helps identify missed revenue opportunities and enhances market positioning. In the U.S., formularies detail drug coverage, pricing tiers, and management requirements, making accurate analysis crucial for pharma firms. The CVA tool significantly reduces manual labor, uncovering discrepancies in drug listings, and validating payments against contracts. It allows for the identification of formulary types, extraction of relevant drugs, and visualizations for further analysis. By pinpointing inconsistencies, the tool can reveal substantial revenue gains, ensuring compliance and optimized drug placement. With proven success—processing thousands of formularies and data points—the EncompaaS CVA tool empowers pharmaceutical companies to maximize revenue and gain a competitive edge in the marketplace.

Source link